ArticleCurrent protocols2025
Generation of Conformation-Specific Monoclonal Antibodies for Integral Membrane Proteins.
Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Structural and mechanistic insights into gating and allosteric modulation of GluN1-GluN3A NMDA receptors.Nature structural & molecular biology · 2026Article
- AMPAR immunization induces progressive autoimmune encephalitis with autoreactive B cells in the brain.bioRxiv : the preprint server for biology · 2026Article
- Cryo-EM of autoantibody-bound NMDA receptors reveals antigenic hotspots in an active immunization model of anti-NMDAR encephalitis.Science advances · 2026Article
- Dimeric gold nanoparticles enable multiplexed labeling in cryoelectron tomography.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Generation of Conformation-Specific Monoclonal Antibodies for Integral Membrane Proteins.Current protocols · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Antibodies and their antigen-binding fragments, including fragment antigen-binding domains (Fabs) and single-chain variable fragments (scFvs), are extraordinary tools in all fields of biology, particularly in neuroscience, where they have been utilized for imaging, detection, and quantification studies. Most antibodies bind to unstructured or linear epitopes. Conformation-specific antibodies, by contrast, bind to 3D epitopes, recognizing native conformations of the target antigen, and have proven highly useful in X-ray crystallography as crystallization chaperones and in cryo-electron microscopy as fiducial markers. Moreover, because conformation-specific antibodies recognize 3D shapes of the antigen, they often have exquisite specificity and are useful in immunofluorescence studies and in isolation of antigen from native tissues. Over the past decade, our group has devoted effort to developing murine monoclonal antibodies (mAbs) against important synaptic receptors, particularly ionotropic glutamate receptors (iGluRs) and their auxiliary proteins. We have developed reproducible methods for generating high-quality mAbs for structural, biochemical, and imaging studies. In this article, we show how to prepare proteoliposomes (PLs), carry out immunization and track the immune response, perform hybridoma generation, and analyze the specificity, cross-reactivity, and competition of mAb binding via enzyme-linked immunosorbent assay and fluorescence-detection size-exclusion chromatography. Our PL-based method produces high-affinity, conformation-specific antibodies targeting diverse synaptic membrane receptors in 4 months. Here, we describe the relevant protocols in detail and document the mAbs, Fabs, and scFvs that we have produced against iGluRs and their auxiliary subunits. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Generation of conformation-specific antibodies for integral membrane proteins Support Protocol 1: Detection of conformational antibodies using ELISA Basic Protocol 2: Expression and purification of monoclonal antibodies and their derivatives Support Protocol 2: Concentration and clarification of insect cell supernatant for Fab purification Support Protocol 3: Measurement of ionotropic glutamate receptor binding kinetics using Octet BLI System.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.